Drug ID: | NPD3703 |
Drug Name: | HF-0220 |
Molecular Formula: | C19H30O3 |
Canonical SMILES: | O[C@H]1CC[C@]2([C@H](C1)C[C@@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CCC2=O)C)O)C |
Standard InCHI: | InChI=1S/C19H30O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h11-15,17,20-21H,3-10H2,1-2H3/t11-,12+,13+,14+,15+,17+,18+,19+/m1/s1 |
Standard InCHIKey: | VFPMCLQMAUVEHD-UCPSWNCLSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB003651 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 306.22 |
ALogP | -0.5276 |
MLogP | 3.22 |
XLogP | 2.426 |
HDA | 3 |
HBD | 2 |
Rotatable Bonds | 4 |
TPSA | 57.53 |
RO5 Violation | 0 |